JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB11820

Anti-HLA E antibody [MEM-E/07]

5

(3 Reviews)

|

(8 Publications)

Mouse Monoclonal HLAE antibody. Suitable for IHC-P, Flow Cyt and reacts with Human samples. Cited in 8 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human HLA-E.

View Alternative Names

HLA-6.2, HLAE, HLA-E, MHC class I antigen E

2 Images
Flow Cytometry - Anti-HLA E antibody [MEM-E/07] (AB11820)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-HLA E antibody [MEM-E/07] (AB11820)

Flow cytometry analysis showing separation of HLA-E transfected LCL cells stained using ab11820 (concentration in sample 2 µg/ml, red-filled) from HLA-E transfected LCL cells stained using mouse IgG1 isotype control purified antibody (concentration in sample 2 µg/ml, same as HLA-E purified antibody concentration, black-dashed).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HLA E antibody [MEM-E/07] (AB11820)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HLA E antibody [MEM-E/07] (AB11820)

Immunohistochemistry parafin embedded sections staining of huam spleen tissue using ab11820.

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

MEM-E/07

Isotype

IgG1

Carrier free

No

Reacts with

Human

Applications

IHC-P, Flow Cyt

applications

Immunogen

Recombinant Full Length Protein corresponding to Human HLA-E.

P13747

Specificity

The antibody recognized native surface-expressed HLA E, but not denaturated heavy chain of HLA E. The published results revealed that the antibody cross-reacts with some classical MHC Class I molecules: HLA B7 (strongly), HLA B8 (moderately), HLA B27, HLA-B44 (weakly).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "10 g/mL", "IHCP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1-4 µg/mL", "FlowCyt-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Purification notes
Purified from hybridoma culture supernatant by protein A-affinity chromatography.
Storage buffer
pH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Non-classical major histocompatibility class Ib molecule involved in immune self-nonself discrimination. In complex with B2M/beta-2-microglobulin binds nonamer self-peptides derived from the signal sequence of classical MHC class Ia molecules (VL9 peptides - VMAPRT[V/L][L/V/I/F]L) (PubMed : 18083576, PubMed : 18339401, PubMed : 35705051, PubMed : 37264229, PubMed : 9754572). Peptide-bound HLA-E-B2M heterotrimeric complex primarily functions as a ligand for natural killer (NK) cell inhibitory receptor KLRD1-KLRC1, enabling NK cells to monitor the expression of other MHC class I molecules in healthy cells and to tolerate self (PubMed : 17179229, PubMed : 18083576, PubMed : 37264229, PubMed : 9486650, PubMed : 9754572). Upon cellular stress, preferentially binds signal sequence-derived peptides from stress-induced chaperones and is no longer recognized by NK cell inhibitory receptor KLRD1-KLRC1, resulting in impaired protection from NK cells (PubMed : 12461076). Binds signal sequence-derived peptides from non-classical MHC class Ib HLA-G molecules and acts as a ligand for NK cell activating receptor KLRD1-KLRC2, likely playing a role in the generation and effector functions of adaptive NK cells and in maternal-fetal tolerance during pregnancy (PubMed : 30134159, PubMed : 37264229, PubMed : 9754572). Besides self-peptides, can also bind and present pathogen-derived peptides conformationally similar to VL9 peptides to alpha-beta T cell receptor (TCR) on unconventional CD8-positive cytotoxic T cells, ultimately triggering antimicrobial immune response (PubMed : 16474394, PubMed : 20195504, PubMed : 30087334, PubMed : 34228645). Presents HIV gag peptides (immunodominant KAFSPEVIPMF and subdominant KALGPAATL epitopes) predominantly to CD8-positive T cell clones expressing a TRAV17-containing TCR, triggering HLA-E-restricted T cell responses (PubMed : 34228645). Presents mycobacterial peptides to HLA-E-restricted CD8-positive T cells eliciting both cytotoxic and immunoregulatory functions (PubMed : 20195504, PubMed : 35705051).. (Microbial infection) Viruses like human cytomegalovirus have evolved an escape mechanism whereby virus-induced down-regulation of host MHC class I molecules is coupled to the binding of viral peptides to HLA-E, restoring HLA-E expression and inducing HLA-E-dependent NK cell immune tolerance to infected cells.. (Microbial infection) May bind HIV-1 gag/Capsid protein p24-derived peptide (AISPRTLNA) on infected cells and may inhibit NK cell cytotoxicity, a mechanism that allows HIV-1 to escape immune recognition.. (Microbial infection) Upon SARS-CoV-2 infection, may contribute to functional exhaustion of cytotoxic NK cells and CD8-positive T cells (PubMed : 32859121). Binds SARS-CoV-2 S/Spike protein S1-derived peptide (LQPRTFLL) expressed on the surface of lung epithelial cells, inducing NK cell exhaustion and dampening of antiviral immune surveillance (PubMed : 32859121).
See full target information HLA-E

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular sciences 23: PubMed36142211

2022

The Relative Abundances of Human Leukocyte Antigen-E, α-Galactosidase A and α-Gal Antigenic Determinants Are Biased by Trichostatin A-Dependent Epigenetic Transformation of Triple-Transgenic Pig-Derived Dermal Fibroblast Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Marcin Samiec,Jerzy Wiater,Kamil Wartalski,Maria Skrzyszowska,Monika Trzcińska,Daniel Lipiński,Jacek Jura,Zdzisław Smorąg,Ryszard Słomski,Małgorzata Duda

European journal of immunology 46:929-40 PubMed26711740

2016

Microenvironmental stresses induce HLA-E/Qa-1 surface expression and thereby reduce CD8(+) T-cell recognition of stressed cells.

Applications

Unspecified application

Species

Unspecified reactive species

Takanori Sasaki,Takayuki Kanaseki,Yosuke Shionoya,Serina Tokita,Sho Miyamoto,Eri Saka,Vitaly Kochin,Akira Takasawa,Yoshihiko Hirohashi,Yasuaki Tamura,Akihiro Miyazaki,Toshihiko Torigoe,Hiroyoshi Hiratsuka,Noriyuki Sato

Immunology letters 162:94-100 PubMed25086398

2014

Inhibition of ERK and proliferation in NK cell lines by soluble HLA-E released from Japanese encephalitis virus infected cells.

Applications

Unspecified application

Species

Unspecified reactive species

Shwetank,Onkar Sanjay Date,Ennio Carbone,Ramanathapuram Manjunath

PloS one 8:e79197 PubMed24236107

2013

Infection of human endothelial cells by Japanese encephalitis virus: increased expression and release of soluble HLA-E.

Applications

Unspecified application

Species

Human

Shwetank,Onkar S Date,Kwang S Kim,Ramanathapuram Manjunath

PloS one 7:e46120 PubMed23049954

2012

Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients.

Applications

Flow Cyt

Species

Unspecified reactive species

Pernille B Jørgensen,Astrid H Livbjerg,Hans J Hansen,Thor Petersen,Per Höllsberg

European journal of immunology 42:217-27 PubMed21928277

2011

Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34-56 peptide in incomplete adjuvant.

Applications

Unspecified application

Species

Unspecified reactive species

S Anwar Jagessar,Nicole Heijmans,Erwin L A Blezer,Jan Bauer,Jeroen H Blokhuis,Jacqueline A M Wubben,Jan W Drijfhout,Peter J van den Elsen,Jon D Laman,Bert A 't Hart

The Journal of experimental medicine 207:2033-41 PubMed20713594

2010

The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation.

Applications

WB

Species

Human

Boyoun Park,Eric Spooner,Brandy L Houser,Jack L Strominger,Hidde L Ploegh

Human immunology 66:1-12 PubMed15620456

2004

HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines.

Applications

Unspecified application

Species

Unspecified reactive species

Giulio Lelio Palmisano,Elisabetta Contardi,Anna Morabito,Vittoria Gargaglione,Giovanni Battista Ferrara,Maria Pia Pistillo
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com